You are here

Gold Standard Task Force Leadership

The Gold Standard Task Force is comprised of one representative from each Gold Standard accredited organization that is also a Member in good standing of the CEO Roundtable on Cancer.

CEO Cancer Gold Standard™ Task Force Leadership

David Shepperly, MD, MHS, FACOEM

David Shepperly, MD, MHS, FACOEM

Co-Chair, CEO Cancer Gold Standard™ Task Force

Executive Director Occupational Health, Bristol Myers Squibb

Marcelo C. Targino, MD, MPH

Marcelo C. Targino, MD, MPH

Co-Chair, CEO Cancer Gold Standard™ Task Force

Chief Health Officer and Corporate Medical Director, Johnson & Johnson

Dr. Michelle Bennet

L. Michelle Bennett, Ph.D.

Gold Standard Task Force, Member

Director, Center for Research Strategy, National Cancer Institute

Chief Innovation Officer (Acting), National Institute of Environmental Health Sciences

Otis W. Brawley, MD

Otis W. Brawley, MD, MACP

Gold Standard Task Force, Member

Bloomberg Distinguished Professor, Johns Hopkins University

Ron Z. Goetzel, PhD

Ron Z. Goetzel, PhD

Gold Standard Task Force, Member

Senior Scientist And Director, Institute for Health and Productivity Studies, Johns Hopkins Bloomberg School of Public Health

The CEO Cancer Gold Standard™ Task Force:
  • Helps ensure the continued promulgation of the Gold Standard and that the program evolves in a manner that continues to foster improved health and wellness for employees and their family members
  • Reviews the program to ensure that it remains current with scientific evidence and applicable laws
  • Debates and/or recommends changes and/or enhancements to the Gold Standard requirements and/or accreditation process
  • Holds at least one meeting per year in addition to exchanging information within and among the Task Force through conference calls, etc.